Europe Protein Expression Market Report and Forecast 2024-2032

Europe Protein Expression Market Outlook

The global protein expression market size was valued at USD 3 billion in 2023, with Europe holding a significant market share. The market is driven by the increased protein-based research and development activities across the region. It is expected to grow at a CAGR of 5.40% during the forecast period of 2024-2032, with the values likely to attain USD 4.9 billion by 2032.

Key Takeaways

• The market is poised toward an upwards trajectory due to increased investment activities in the region. The German government invested EUR 38 million (nearly USD 41 million) in the protein transition in the 2024 federal budget.

• The Europe protein expression market share is likely to be driven by increasing partnership activities between market players. The market players strategically collaborating to increase the production of spider silk proteins, are predicted to play a pivotal role in the biomedical, cosmetics, and textiles industries.

• The opening of a new state-of-the-art protein production facility by BioAscent is anticipated to significantly fuel the market growth, indicating the prevalence of infrastructure improvements and investments.

Europe Protein Expression Market Analysis 

The market is poised to be driven by the heavy government investments in the protein transition to support and promote alternative proteins. The investment is focused on human nutrition, expanding public research for plant-based foods and cultivated meat, and establishing the Proteins-of-the-Future Centre. In November 2023, the Budget Committee of the German Bundestag announced an EUR 38 million (nearly USD 41 million) investment for protein transition in the federal budget 2024. This strategic move may significantly impact the Europe healthcare domain. The technologies used in the production of alternative proteins can also be used to produce pharmaceutical proteins, contributing to the Europe protein expression market growth.

The market is witnessing significant moves by market players influencing the market. For example, In February 2024, BioAscent, a leading provider of integrated drug discovery services opened its state-of-the-art protein production facility.  This move showcased the latest investment made by the company enhancing its in-house drug discovery capabilities with the ability to deliver protein production. The facility is announced to be run by well-experienced industry experts ensuring quality outcomes and propelling market growth. The investment in advanced technologies in the facility such as FPLC (fast protein liquid chromatography), high-pressure homogeniser, shaking incubators, along with a sonicator, and a Category II tissue culture lab, representing the involvement of technologically advanced equipment in the facility.

The Europe protein expression market share is projected to be driven by the rising demand for personalized therapeutics and the rapidly growing research and development activities that support protein expression. Additionally, the market is driven by strategic partnerships between market players to upscale the production and application of innovative materials in the healthcare sector. One such example is the strategic collaboration of AMSilk GmbH (Neuried, Germany), advanced materials specialist, and 21st.BIO (Copenhagen) biotech production specialist. The announcement was made in January 2024 about the companies coming together to accelerate the production of AMSilk’s E. coli-based recombinant spider silk protein. With the potential application of AMSilk's spider silk-based protein in biomedicals, this collaboration is poised to accelerate its production, potentially increasing its application in healthcare such as wound healing, and drug delivery systems among others. AMSilk's spider silk proteins, derived from plants, reduce CO2 emissions by 90%, use less land and water, and are animal-free, benefiting textiles, homecare, and biomedical industries.

Europe Protein Expression Market Segmentation

The market report offers a detailed analysis of the market based on the following segments:

Europe Protein Expression Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

• Merck KGaA

• Sartorius AG

• Lonza Group AG

• Oxford Expression Technologies Ltd.

• Thermo Fisher Scientific Inc.

• Agilent Technologies, Inc.

• Danaher Corporation

• Promega Corporation

• QIAGEN

• GenScript Biotech Corporation

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Highlights of the Report